We recruited 20 medical and pharmaceutical directors from national and regional plans who are involved in pharmaceutical and therapeutics committees to participate in the study. We conducted in-depth ...

Steve Pickette, PharmD, BCPS, explains that artificial intelligence (AI)–driven formulary analysis can significantly enhance the efficiency and accuracy of drug selection processes by rapidly ...

Health systems’ pharmaceutical spending is expected to rise by up to 6 percent in 2019, according to a study published in the American Journal of Health-System Pharmacy. For these organizations — ...

Margaret Krackeler, MD, of Kaiser Permanente Northern California, shares lessons on implementing evidence-based formulary changes for patients with CLL. This interview was lightly edited for clarity.

Already available through Abridge's AI-driven clinical decision support (CDS) technology are insights from Wolters Kluwer Health's UpToDate. But later this year, medical research data from NEJM and ...